Cargando…
Prostaglandin-associated periorbitopathy in latanoprost users
PURPOSE: We investigated the incidence of prostaglandin-associated periorbitopathy (PAP) in subjects with glaucoma treated with latanoprost ophthalmic solution. SUBJECTS AND METHODS: One eye and the forehead in 22 subjects were evaluated. All patients had used latanoprost for more than 1 year (range...
Autores principales: | Nakakura, Shunsuke, Yamamoto, Minamai, Terao, Etsuko, Nagatomi, Nozomi, Matsuo, Naoko, Fujisawa, Yausko, Fujio, Yuki, Tabuchi, Hitoshi, Kiuchi, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284030/ https://www.ncbi.nlm.nih.gov/pubmed/25565768 http://dx.doi.org/10.2147/OPTH.S75651 |
Ejemplares similares
-
Cross-Sectional Study of the Association between a Deepening of the Upper Eyelid Sulcus-Like Appearance and Wide-Open Eyes
por: Nakakura, Shunsuke, et al.
Publicado: (2014) -
One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl
por: Oogi, Satomi, et al.
Publicado: (2020) -
Prostaglandin-associated periorbitopathy
por: Shrirao, Neha, et al.
Publicado: (2016) -
Iris Morphological Features in Patients with 360° Angle-Closure Neovascular Glaucoma: An Anterior Segment Optical Coherence Tomography Study
por: Kobayashi, Yui, et al.
Publicado: (2018) -
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)